In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...
A Bristol Myers Squibb Co. patent detailed new substituted phenyl oxooxazolyl piperidine dione molecular glue degraders acting as DNA-binding protein Ikaros (IKZF1), zinc finger protein Helios (IKZF2) ...
In March 2025, Magnet Biomedicine formed a partnership and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapeutics. In January 2025 ...
Although many potential molecular glue compounds are being identified through drug discovery methods, only a few have advanced to clinical trials to evaluate their effectiveness in treating diseases.
In March 2025, Magnet Biomedicine formed a partnership and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapeutics. In January 2025 ...
The temptation might arise to use wood glue or common white glues for your project, assuming that standard adhesives will suffice for plastic. Nevertheless, such misapprehensions could be detrimen ...
Recent advancements in automated protein purification stress the importance of efficiency, scalability, and yield consistency. This eBook compares different purification platforms, highlighting their ...
Monte Rosa's valuation gap to narrow, says Piper Sandler in new stock rating On Thursday, Piper Sandler kept its Overweight rating on Monte Rosa Therapeutics (NASDAQ:GLUE) stock with a steady ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results